vs
indie Semiconductor, Inc.（INDI）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是indie Semiconductor, Inc.的1.3倍（$75.5M vs $58.0M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -0.0%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-16.1M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 5.3%）
indie Semiconductor是一家无晶圆厂半导体企业，专注于设计高性能混合信号及嵌入式片上系统解决方案，核心面向汽车领域，产品覆盖高级驾驶辅助、车载信息娱乐、车联网及电动汽车场景，服务全球汽车整车厂商及一级供应商。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
INDI vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.3倍
$58.0M
营收增速更快
PBYI
高出27.7%
-0.0%
自由现金流更多
PBYI
多$30.5M
$-16.1M
两年增速更快
PBYI
近两年复合增速
5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $58.0M | $75.5M |
| 净利润 | $-31.2M | — |
| 毛利率 | 37.3% | 69.3% |
| 营业利润率 | -58.5% | 22.7% |
| 净利率 | -53.8% | — |
| 营收同比 | -0.0% | 27.7% |
| 净利润同比 | 9.1% | — |
| 每股收益（稀释后） | $-0.16 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INDIPBYI
| Q4 25 | $58.0M | $75.5M | ||
| Q3 25 | $53.7M | $54.5M | ||
| Q2 25 | $51.6M | $52.4M | ||
| Q1 25 | $54.1M | $46.0M | ||
| Q4 24 | $58.0M | $59.1M | ||
| Q3 24 | $54.0M | $80.5M | ||
| Q2 24 | $52.4M | $47.1M | ||
| Q1 24 | $52.4M | $43.8M |
净利润INDIPBYI
| Q4 25 | $-31.2M | — | ||
| Q3 25 | $-38.3M | $8.8M | ||
| Q2 25 | $-39.0M | $5.9M | ||
| Q1 25 | $-34.5M | $3.0M | ||
| Q4 24 | $-34.4M | — | ||
| Q3 24 | $-49.7M | $20.3M | ||
| Q2 24 | $-19.2M | $-4.5M | ||
| Q1 24 | $-31.2M | $-4.8M |
毛利率INDIPBYI
| Q4 25 | 37.3% | 69.3% | ||
| Q3 25 | 40.1% | 77.7% | ||
| Q2 25 | 40.6% | 76.5% | ||
| Q1 25 | 41.7% | 77.1% | ||
| Q4 24 | 42.6% | 76.4% | ||
| Q3 24 | 39.3% | 63.9% | ||
| Q2 24 | 42.2% | 77.4% | ||
| Q1 24 | 42.5% | 75.5% |
营业利润率INDIPBYI
| Q4 25 | -58.5% | 22.7% | ||
| Q3 25 | -71.4% | 17.6% | ||
| Q2 25 | -83.3% | 12.7% | ||
| Q1 25 | -72.0% | 8.7% | ||
| Q4 24 | -58.4% | 22.6% | ||
| Q3 24 | -92.5% | 27.4% | ||
| Q2 24 | -70.0% | -4.6% | ||
| Q1 24 | -94.8% | -5.3% |
净利率INDIPBYI
| Q4 25 | -53.8% | — | ||
| Q3 25 | -71.3% | 16.2% | ||
| Q2 25 | -75.6% | 11.2% | ||
| Q1 25 | -63.9% | 6.5% | ||
| Q4 24 | -59.2% | — | ||
| Q3 24 | -92.1% | 25.2% | ||
| Q2 24 | -36.6% | -9.6% | ||
| Q1 24 | -59.6% | -11.0% |
每股收益（稀释后）INDIPBYI
| Q4 25 | $-0.16 | $0.26 | ||
| Q3 25 | $-0.19 | $0.17 | ||
| Q2 25 | $-0.20 | $0.12 | ||
| Q1 25 | $-0.18 | $0.06 | ||
| Q4 24 | $-0.18 | $0.40 | ||
| Q3 24 | $-0.28 | $0.41 | ||
| Q2 24 | $-0.11 | $-0.09 | ||
| Q1 24 | $-0.19 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $145.5M | $97.5M |
| 总债务越低越好 | $353.4M | $22.7M |
| 股东权益账面价值 | $358.0M | $130.3M |
| 总资产 | $840.8M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.99× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资INDIPBYI
| Q4 25 | $145.5M | $97.5M | ||
| Q3 25 | $160.9M | $94.4M | ||
| Q2 25 | $192.6M | $96.0M | ||
| Q1 25 | $236.6M | $93.2M | ||
| Q4 24 | $274.2M | $101.0M | ||
| Q3 24 | $96.9M | $96.7M | ||
| Q2 24 | $112.3M | $96.8M | ||
| Q1 24 | $138.2M | $107.2M |
总债务INDIPBYI
| Q4 25 | $353.4M | $22.7M | ||
| Q3 25 | $353.5M | $34.0M | ||
| Q2 25 | $352.5M | $45.3M | ||
| Q1 25 | $379.0M | $56.7M | ||
| Q4 24 | $381.3M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益INDIPBYI
| Q4 25 | $358.0M | $130.3M | ||
| Q3 25 | $369.2M | $115.3M | ||
| Q2 25 | $390.4M | $104.7M | ||
| Q1 25 | $405.6M | $97.1M | ||
| Q4 24 | $417.9M | $92.1M | ||
| Q3 24 | $458.6M | $71.1M | ||
| Q2 24 | $470.7M | $48.5M | ||
| Q1 24 | $432.9M | $51.0M |
总资产INDIPBYI
| Q4 25 | $840.8M | $216.3M | ||
| Q3 25 | $855.1M | $202.9M | ||
| Q2 25 | $867.6M | $194.9M | ||
| Q1 25 | $909.0M | $196.2M | ||
| Q4 24 | $941.4M | $213.3M | ||
| Q3 24 | $797.5M | $220.7M | ||
| Q2 24 | $797.3M | $205.0M | ||
| Q1 24 | $803.6M | $214.1M |
负债/权益比INDIPBYI
| Q4 25 | 0.99× | 0.17× | ||
| Q3 25 | 0.96× | 0.30× | ||
| Q2 25 | 0.90× | 0.43× | ||
| Q1 25 | 0.93× | 0.58× | ||
| Q4 24 | 0.91× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-16.1M | $14.4M |
| 自由现金流率自由现金流/营收 | -27.8% | 19.1% |
| 资本支出强度资本支出/营收 | 3.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-71.4M | $41.7M |
8季度趋势，按日历期对齐
经营现金流INDIPBYI
| Q4 25 | $-14.4M | $14.4M | ||
| Q3 25 | $-6.2M | $9.7M | ||
| Q2 25 | $-7.6M | $14.1M | ||
| Q1 25 | $-29.0M | $3.6M | ||
| Q4 24 | $-6.7M | $15.6M | ||
| Q3 24 | $-22.8M | $11.0M | ||
| Q2 24 | $-19.7M | $1.0M | ||
| Q1 24 | $-9.3M | $11.2M |
自由现金流INDIPBYI
| Q4 25 | $-16.1M | $14.4M | ||
| Q3 25 | $-10.3M | $9.7M | ||
| Q2 25 | $-13.6M | $14.1M | ||
| Q1 25 | $-31.4M | $3.6M | ||
| Q4 24 | $-8.6M | $15.6M | ||
| Q3 24 | $-29.3M | $11.0M | ||
| Q2 24 | $-23.4M | $1.0M | ||
| Q1 24 | $-11.7M | — |
自由现金流率INDIPBYI
| Q4 25 | -27.8% | 19.1% | ||
| Q3 25 | -19.2% | 17.7% | ||
| Q2 25 | -26.4% | 26.8% | ||
| Q1 25 | -58.0% | 7.7% | ||
| Q4 24 | -14.8% | 26.4% | ||
| Q3 24 | -54.3% | 13.7% | ||
| Q2 24 | -44.7% | 2.1% | ||
| Q1 24 | -22.3% | — |
资本支出强度INDIPBYI
| Q4 25 | 3.0% | 0.0% | ||
| Q3 25 | 7.8% | 0.0% | ||
| Q2 25 | 11.6% | 0.0% | ||
| Q1 25 | 4.4% | 0.1% | ||
| Q4 24 | 3.2% | 0.0% | ||
| Q3 24 | 12.1% | 0.0% | ||
| Q2 24 | 7.0% | 0.0% | ||
| Q1 24 | 4.4% | 0.0% |
现金转化率INDIPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INDI
| Products | $55.7M | 96% |
| Services | $2.3M | 4% |
PBYI
暂无分部数据
